Comments to FDA: Scientific Data About Products Containing Cannabis or Cannabis Derived Compounds

Share page:
Docket Number:

As many dietary supplement products are being marketed as containing cannabidiol (CBD), CHPA has an interest in this subject and we presented oral comments at FDA’s May 31, 2019, public hearing. These written comments supplement our oral remarks.